Altair
Skip to content

Trading Analysis Report: MRVL

Analysis date: 2026-10-14 · Model: claude-opus-5-5 · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Underweight
  • Generated: 2026-10-14 15:09:44
  • TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Underweight

Executive Summary: Underweight MRVL: cut to about 40% of a standard allocation by Monday. Sell one quarter in the first half hour tomorrow, then check the option chain once at mid-morning; hold 50% only if a put spread costs no more than a quarter of its strike width on an expiry past the late-October FOMC and hyperscaler earnings, otherwise sell ten more points and hold 40%. Work a second quarter on 250-255 limits through Friday and sell any unfilled part Monday, or sell it at market at the mid-morning look if price is under 239.31. On unhedged shares, step to 35% on a daily close below 225, 25% below 216.57 and exit below 206; flat accounts should not initiate at 245, nobody should short this 2.26-beta name, proceeds stay in cash, and full weight returns only on clean filings plus a weekly close above the weekly SuperTrend (286.49 now, re-read each weekend), over a 4-8 week horizon with a 225 target.

PRICE TARGET: 225. Valuation methods are unusable: the forward EPS was discredited and a ~1% FCF yield gives no anchor. So the target is a technical objective, the 50% retracement of the run from the 2026-07-29 close of 163.36 to the 2026-10-06 close of 286.95: 286.95 - 0.5 x (286.95 - 163.36) = 286.95 - 61.80 = 225.15, rounded to 225. - Cross-checks: repeating 10-14's 23.45-point drop lands at ~221.8, and one ATR (15.80) below the 239.31-240.96 cluster gives ~223.5-225.2. - That is ~8.3% below 245.28, consistent with an Underweight over 4-8 weeks. Deeper references are 216.57, 206-210 and the 174 200 SMA.

Current Price: 245.28

Price Target: 225.0

Confidence: Medium

Time Horizon: 4-8 weeks

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: Since I'm opening, I'll make the case and then take on what I expect the other two to say.

Selling half here is the aggressive move, not the timid one. Aggressive doesn't mean riding a full-size position through a breakdown because the long-term story is good. It means acting early on an edge and keeping capital mobile enough to attack the next opportunity. MRVL just fell 8.7% in a day, from 268.73 to 245.28, closing within 18 cents of the low. The weekly SuperTrend is down at 286.49, and the weekly TD Sequential sell-setup is complete at 9. The MACD crossed bearish on 10-12 and the histogram has accelerated down since: +1.07, -0.13, -0.80, -2.78. Price has lost the 10 EMA and the Bollinger midline, and the rebound topped at 301.20 against 324.05 in June, a lower high.

The nearest support cluster, 239.31 to 240.96, is only about 0.27 ATR below price. That's not a floor, it's a line the stock will probably touch on a normal day. The plan accounts for this by completing the trim on a daily close below 240.96 on 1.3x volume.

The neutral analyst will likely say the picture is mixed: RSI is 44, nothing is stretched past a z-score of 2, and price is still above the 50 and 200 day averages. I read that the other way. No washout means the selling hasn't exhausted itself. ADX collapsing from 35.5 to 16 while price breaks down looks like a regime change, not a calm market. With a beta of 2.26 and ATR at 6.4% of price, "nothing is stretched" is not a reason to sit at full size. It's room to fall.

The macro backdrop reinforces this. Polymarket has no 2026 cuts at 97%, another hike at 86% (up 8 points on the week), and three-hike odds up almost 10 points. Cuts are priced out, there's no recession to force the Fed's hand, and a stock at 23x sales is the textbook casualty of that mix. The tape also shows distribution behavior. MRVL fell 4.62% on a day when AI interconnect chips entered customer sampling, and ASML's strong earnings didn't stop the chip slump. When good news gets sold, that's what a market looks like when it wants to sell.

The conservative analyst will probably say exit completely, or even short, given ~77x EBITDA, ~91x vendor FCF and a forward P/E that needs EPS to leap from $0.37 of GAAP in the first half to $7.28. I agree the fundamentals deserve skepticism. Opex rose from $712M to $996M in about three quarters, and Q2 FCF was flat while revenue grew 13%. Diluted shares look roughly 8% higher, and there's an unexplained $305M gap below the operating line in Q1. Insiders sold about $45.8M this year with no open-market buys, including none anywhere near the $163 July low. Yes, the sales look programmatic, but nobody stepped up at those prices either.

But a full exit or a short is where I disagree. Revenue grew 36.5% year over year, gross margin has risen six straight quarters to 53.2%, and the monthly trend is still up with the stock 41% above its 200 SMA. Shorting a name that ran 76% in ten weeks, with a 2.26 beta, is how you get squeezed on a single TSM headline. And a full exit on a one-day, possibly partial bar means selling the low. The plan sells into bounces toward 250 to 255 with limits, so a rebound improves the exit instead of hurting it. Keeping half also leaves us in the stock if the weekly line at 286.49 gets reclaimed. That is a defined invalidation, about 2.6 ATR away, so it won't be tripped by noise.

The trim also frees capital. If this goes to the 206 to 217 zone, or toward the 200 SMA at 174, cash is worth far more than a full position held through the drop. That's the real upside of selling: money you can redeploy into the next leg at much better prices. The staged triggers, a quarter position below 216.57 and out below 206, mean we scale the decision with the evidence instead of guessing.

Finally, I'd hold full size only if the burden of proof had been met, and it hasn't. The 10-Q, the Q3 guide and the investor-day material are unread, and users on StockTwits are split on whether investor day was a "major setback" or "the top." I'd rather be half-sized and wrong on the downside than full-sized on a thesis I haven't verified.

I'd flag the caveats. The latest bar may be partial, FRED macro data was unavailable, and the sentiment sample is a single afternoon with low confidence, so reconfirm the levels at the close. Nothing there overturns the call. Trim to half, sell strength, and keep the dry powder. Aggressive Analyst: Let me go through these in order. I think we've converged more than the tone suggests, so the remaining gaps are worth being precise about.

The conservative says a half trim isn't aggressive. I don't care what it's called. All three of us now want to sell about half, not short, and not initiate at 245, so the fight is over sequencing. On sequencing, the conservative handed me the most aggressive piece of the plan: sell a quarter early instead of waiting for a bounce that may not come. I'll take it, because it makes a barbell. A tranche at the open protects the gap-down tail, and a tranche on limits at 250 to 255 harvests the gap-up tail. The claim that 252.5 assumes a bounce the tape hasn't shown doesn't hold. Today's range ran from 245.10 to 264.30, and 252.5 is about 7 points, under half an ATR, above the close. On a stock that moves 6.4% a day, that's a quiet afternoon. The neutral is right that "market after three sessions" is just a calendar rule. I'd tie the deadline to Friday's weekly close and let a reclaim of 264 to 266 cancel the sale.

On the trigger, I concede. The 1.3x volume filter was calibrated to a crash day. A close below 239.31 on at least average volume clears the lower band, the 50-day and the daily SuperTrend at once, and two straight closes below 240.96 works as the fallback for a slow grind.

I also have to give some things up. Both of you caught me on ADX. At 16, with no DI lines pulled, it says the trend faded, not which way. Calling it a regime change was a stretch, and the case never needed it. It rests on the lower high at 301.20 against 324.05, the bearish MACD cross with an accelerating histogram, and price under the 10 EMA and the midline. The neutral is also right that October 6 is better distribution evidence than today. That bar traded 51 million shares, more than double a normal day, spiked to 301, and closed 14 points off the high. That's the rejection, and it helps my case. I'll lean on hot CPI, rising yields and ASML's beat failing to help, since none of that depends on thin Polymarket books. The insider point is color, not evidence, given blackout windows and the programmatic selling.

What I won't give up is the room-to-fall argument. The neutral says the stock has already given back 14.5%. But the run was 163 to 287, and 245 is only about a third of it retraced. A 38% retrace is the 240 cluster we're sitting on, 50% is 225, and 61.8% is the 206 to 210 area where the early September closes sit. We're on the first rung of that ladder with RSI at 44, which isn't washed out. The conservative's "10 percent hole" from 240.96 to 216.57 is about 1.5 ATR, roughly two ordinary days on this stock. That's a reason to put a rung in it, so I'll take the neutral's 225 checkpoint on a daily close. It isn't a reason to buy insurance.

I'm against the collar. Buying puts after an 8.7% day means paying peak implied vol, and none of us has seen the chain. A short call at 286 to 290 caps the retained half at the exact line where the plan says we come back in. The conservative is right that 286.49 isn't a stop on anything we hold, so call it an invalidation line on the ticket. The neutral is right that it ratchets lower in a downtrend, so the call would get worse over time. If the chain is liquid and cheap, a small put spread on part of the retained half is fine, since options are the only thing that helps in a gap. Otherwise selling shares is the hedge, with no premium and no cap. The neutral's arithmetic is also the best answer to the conservative. The retained half falling 8 to 14% costs 4 to 7% of the original position, and that's the price of still owning the reclaim.

On fundamentals, the conservative says growth and margins were also true at 316 and the stock still hit 163. Agreed. That's why fundamentals aren't a reason to hold full size, and also why I won't short. The neutral is right that the setup differs, since that drop followed a 220% parabola and this one follows a recovery with a rising 50-day. The volatility is the same, though, and volatility is the sizing argument.

Read the filings today. Q2 has presumably been public for weeks while the stock rallied, so I expect confirmation more than surprise, and the investor day is the real unknown. I'd let the filings gate the second tranche. If organic growth is well below the headline or the guide doesn't support the forward numbers, go to a quarter immediately.

On the proceeds, I agree they shouldn't go into the next high-beta AI name. My point was the option to rebuy MRVL itself lower, on a rule like a daily reclaim of the 10 EMA and midline after the cluster holds.

So my plan is a quarter early, a quarter on limits through Friday's weekly close, completion on a close below 239.31, a checkpoint at 225, a quarter position at 216.57, and out below 206. No collar, and an optional put spread if the chain cooperates. The bar may be partial and FRED was down, so reconfirm levels at the close. The call stays Sell. Aggressive Analyst: Start with the arithmetic, because it settles the one argument still live. The conservative said a day like today runs through all three rungs, and it doesn't. Today's close-to-close drop was 23.45, so repeating it from 245.28 closes the stock near 222. That fires the 225 step and nothing else. Reaching the 206 exit takes a 39-point fall, about 2.5 ATR or 16 percent, which is two bad days. The neutral's two-day path also shows what the ladder is worth in the tail: roughly a 10 percent loss on the original position versus 11 percent for sitting still. So I'm done calling the ladder protection. It's a discipline device that stops us from rationalizing a hold through a break, and that's all it needs to be.

That leaves the size of the retained piece and an option as the real protection, and I think we're arguing over very little. Ten points of position, 50 versus 40, is worth a bit under two points of the original position if the stock goes to 190, and about 1.7 if it gets back to the weekly line near 286. That's roughly the same number either way, so I'll take the neutral's rule: price the put spread, buy it only if the debit is under about a third of the strike width, and otherwise hold 40. I'd add one thing on timing. Implied vol is probably at its worst the day after an 8.7% drop on a tape with no bounce. If we want the spread, the cheapest day to buy it is likely the same bounce our 250 to 255 limits are waiting for. I can't confirm that without seeing the chain, but it means the spread and the limit tranche are one trade seen from two sides, and it's a reason not to chase protection at the open.

The real tail protection in this plan is the thing the conservative proposed first, a quarter sold early tomorrow. It costs no premium and it works in a gap. It's also a barbell. If the TSM reaction is ugly, we've already cut. If it's a blowout and the stock gaps toward 255 or 260, we sold a quarter above today's close and the limit tranche probably fills too. I agree with the neutral on waiting the first half hour instead of selling the opening print.

On the 252.5 limit, the conservative is right and I was wrong. "A quiet afternoon" was a bad description. A high under two points above the open and a close 18 cents off the low is one-way traffic, and the range tells us about volatility, not bounce odds. This is the tranche most likely to go unfilled, so I accept Friday's close plus Monday as the backstop. A Friday close above about 265 cancels the sale, and that cancellation is our re-entry for that quarter. For the same reason I'll take the neutral's rebuy rule. The cancel exception covers the quarter we still hold, and the quarter sold at the open was the price of insurance.

The neutral is also right that the retracement levels haven't been checked against MRVL's own bounces, and that "no washout" is the same RSI reading whether the stock falls or snaps back. I'll stop treating 225 and 210 as targets. 225 is a decision point, not a magnet. The RSI reading supports trimming, and we're trimming.

On the Koopmans and Murphy sales, the 30 to 36 percent falls are real, but they argue for the half-size position, not for paying more to protect the half. Half a position falling 36 percent is an 18 percent hit to the original, and full size would have been 36. The trim already cuts that tail in half.

On the filings, I'm with both of them. Ugly means organic growth well below 36.5 percent, a recurring version of the $305M gap, or a guide that doesn't support the forward numbers. I'd read the investor-day material first, since it's the likelier source of anything company-specific in today's drop. Ugly takes us to a quarter immediately. Clean restores nothing, because the trim rests on valuation, the break and the macro, and the 10-Q fixes none of those.

So the call stays Sell. Sell a quarter in the first half hour tomorrow. Work a quarter on limits at 250 to 255 through Friday's close, cancel it if Friday closes above about 265, and otherwise sell Monday. Complete the trim on a close below 239.31 on at least average volume, or on two closes below 240.96. Keep 50% with a spread if it passes the debit test and 40% if not, step to 35% at 225, and on unhedged shares go to 25% at 216.57 and out at 206. Hold the proceeds in cash and don't buy back above our sale price until the weekly line flips. Selling is the aggressive move because cash is the option: if this goes to the 206 to 217 zone, we have capital to use there that a full-size holder doesn't. Reconfirm everything at the close, since the bar may be partial, FRED is down, and the chain, the filings and the TSM print are all still unchecked. Aggressive Analyst: We've converged on almost everything, so I'll concede what's right and spend the rest on the three places I still disagree.

You're both right about the schedule. A Friday close above 265 can't happen without trading through 250 to 255, and a sell limit fills at the open if the stock gaps over it. So the cancel exception was dead on arrival, and I repeated it without checking. That's fine for the barbell, since a gap up on a strong TSM print just fills the limit tranche at a better price than I asked for. The regret case is the half we keep, which is the point of keeping it. I also accept deciding on the spread mid-morning. Waiting for a bounce to buy cheaper insurance means being unprotected in exactly the scenario that needs it. And if the spread fails the cap, selling ten more points that morning is better than carrying unplanned exposure, even though the fill risk is real.

My first disagreement is the cap. The neutral's own example shows a spread at one third of width costs about 2 points of the original position. I ran it against simply holding 40 and keeping 10 in cash. By my rough math, 50 with the spread beats 40 only below about 207 or above about 294 at expiry, and it loses everywhere between. That's nearly the whole plausible range for the next few weeks. A quarter of width helps only a little, moving the breakevens to about 211 and 282. So treat the spread as a pure tail hedge, set the cap at a quarter of width, and expect to end up at 40.

My second is the rebuy rule. Tying it to the lowest sale price means every rung we sell lowers the ceiling. Once we're out at 206, a clean base at 230 is off limits until the weekly flip, so the cash option is dead. I'd use the weighted average of what we actually sold, which still guarantees no round trip loses money overall. I also have to retract my line about redeploying in the 206 to 217 zone, because the ticket sells there. If this plays out, cash gets used lower, near the 200-day at 174 or the July low at 163, and only on a stabilization signal. Selling at 206 and buying at 174 isn't incoherent. It's the whole point of holding cash.

My third is the filings threshold. I side with the neutral's 30% over 25%, and I think it's more likely to fire than he does. Q1's total growth was 27.6%. The balance sheet jump suggests a deal closed during that quarter, so Q1 organic growth was lower still. Q2 total then accelerated about nine points, to 36.5%, against comps that weren't easier, since the prior-year growth was 63% and then 58%. That pattern looks more like a deal going from a partial quarter to a full one than like the base business speeding up. This is inference, because no tool confirms a deal. But it means "ugly" is a live branch, and if it fires, the cut to a quarter position is cheap.

So here's where I land. Selling is still the bold call. The bar may be partial, the reading rests on unread documents and thin macro markets, and the alternative is full size on a thesis nobody here has verified. Sell a quarter in the first half hour tomorrow and work a quarter on limits through Friday, with Monday as the unconditional backstop. Pull the sale to Friday's open if Thursday closes under 239.31, with no volume filter. Price the spread once mid-morning against a quarter-of-width cap, and expect to hold 40 with ten more points sold that morning. Step the unhedged shares to 35 at 225, 25 at 216.57 and out at 206, and treat 286.49 as an invalidation line, not a stop. Proceeds sit in cash until a stabilization signal, with no starter position above our weighted-average sale price and full size only after a weekly flip. These are percentages of whatever the caller holds. Everything still needs reconfirming at the close, because FRED is down, and the chain, the filings and the TSM print are all unchecked. Aggressive Analyst: Most of this is settled, so I'll give back what I owe and then flag the two places where I'd still write the ticket differently.

The conservative is right that I overclaimed on the early quarter. I said that if the TSM reaction is ugly, we've already cut. We haven't. Nothing on this ticket can execute before tomorrow's open, so we carry the full position through tonight's print under every version of this plan. What the early quarter buys is less exposure going into day two, and the chance to sell after the reaction is visible instead of blind. That's worth doing, but it isn't gap protection.

She's also right about the comps. I used the wrong measure. The jump from 27.6% to 36.5% year-over-year growth mostly reflects last year's weak 5.9% Q1-to-Q2 step against this year's 13.3%, so it doesn't point to a deal going from a partial quarter to a full one. I'll move from "the ugly branch is live because of the pattern" to "I can't tell." The neutral's point that a hot AI asset usually costs more than 7.5 times sales also suggests the 30% line won't fire. The $321M sequential step is what the filing has to explain, and that's the right test.

On the spread, I ran the same arithmetic and it matches. At a third of width, 50 with the spread beats 40 with cash only between roughly 145 and 207. It loses about two points everywhere up to 295, and by a retest of the July low the edge is under a point. A quarter-of-width cap is the right bar. Since we all expect the chain to fail it, I'll accept 40 as the default and the spread as an upgrade that has to earn its place. I'll also accept looking once mid-morning. Waiting for cheaper insurance means being unprotected when the stock gaps. And when the spread is closed at the lower strike or at expiry, the hedged shares go with it.

I accept the pairing rule on rebuys. Buying back at P only up to the amount we sold above P means every share we re-buy is cheaper than a share we sold, which a weighted average can't promise. It also doesn't kill the option the way a lowest-sale-price ceiling does. I'll take "buy on the signal, not the level" too. 174 and 163 are places to pay attention, not resting bids.

Now the two places I still differ. First, the one-way filing gate. A clean read restores nothing to the trim, because the trim rests on valuation, the break and the macro. But a clean 10-Q should still count for something on the rebuy side. Suppose the stock gets flushed, stabilizes with a higher low, and the filing is clean. Then I'd let the starter go from ten points to a quarter, still paired and still under our sale prices, with full size waiting on the weekly flip. Otherwise we do all that reading and only ever use it to get smaller.

Second, the silence rule. "No disclosed acquired contribution counts as ugly" only works if the filing contains a business combination. The deal is our inference from the balance sheet, and no tool confirmed it. If the 10-Q shows no acquisition at all, silence isn't a signal about growth. The signal is that we still can't explain a $4.7B step in assets and a $3.9B step in equity, and that's the thing to chase. I'd write the rule that way so we don't trigger "ugly" on a misread of our own inference.

The reason for the call hasn't changed. The valuation leaves no cushion, a 2.26 beta stock has broken its short-term trend, and the thesis is unverified. The edge from the technicals is thin, with ADX at 16 and levels unvalidated, so we size for that instead of betting on it. What the last few rounds improved is the execution.

Here's the ticket as I'd sign it. Tonight, read the investor-day material first, then the 10-Q, with the thresholds written down before opening anything. Ugly means organic growth under 30%, an unexplained residual below the operating line after interest and tax, or a guide that doesn't support the forward numbers. Any of those takes us to a quarter position immediately.

Tomorrow, sell a quarter in the first half hour. Check the chain once, mid-morning. Hold 50 only if the spread costs a quarter of width or less on an expiry that covers the late-October events, with strikes roughly 8% and 20% below the mid-morning price. Otherwise sell ten more and hold 40.

Work a quarter on limits at 250 to 255 through Friday's close and sell whatever is left Monday. If Thursday closes under 239.31, sell it at Friday's open instead, with no volume filter. Unhedged shares step to 35 at a 225 close, 25 at 216.57 and out at 206.

Proceeds stay in cash. Starter buybacks need a stabilization signal with a higher low, the pairing rule and the size cap. Full size waits for a weekly close above the SuperTrend line, which we re-read every weekend because it ratchets lower.

All of this is a percentage of whatever you hold. The latest bar may be partial and the weekly bar isn't final until Friday. The chain, the filings, the TSM print and the FRED macro data are all still unchecked, so reconfirm at the close. The call stays Sell.